Astrana Health Inc (ASTH)
Days of sales outstanding (DSO)
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|
| Receivables turnover | 114.04 | 0.02 | 8.24 | 12.83 | 5.62 | |
| DSO | days | 3.20 | 24,005.62 | 44.29 | 28.45 | 64.97 |
December 31, 2023 calculation
DSO = 365 ÷ Receivables turnover
= 365 ÷ 114.04
= 3.20
The Days of Sales Outstanding (DSO) for Astrana Health Inc fluctuated significantly over the past five years. In 2023, the DSO was 3.20 days, indicating a rapid collection of accounts receivable compared to the previous years. This suggests that the company has been efficient in converting its credit sales into cash.
However, in 2022, there seems to be an outlier where the DSO was recorded as 24,005.62 days, which is highly abnormal and likely a data input error. The DSO was much more reasonable in 2021 at 44.29 days, showing a relatively longer time taken to collect outstanding receivables.
In 2020, the DSO decreased to 28.45 days, indicating an improvement in the company's collection process compared to the prior year. The DSO was significantly higher in 2019 at 64.97 days, suggesting that the company struggled with collecting receivables in a timely manner during that period.
Overall, while there have been fluctuations in Astrana Health Inc's DSO over the years, the most recent data point of 3.20 days in 2023 indicates a positive trend towards more efficient accounts receivable management.